ELIMINATING THE GUESSWORK IN OVER-THE-COUNTER TREATMENT SELECTION: CLINICAL PREDICTORS OF HEARTBURN RESOLUTION WITH OVER-THE-COUNTER ESOMEPRAZOLE
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: JOHNSON, David (Eastern Virginia Medical School, Norfolk, United States)
- Co-author(s): Charles Pollack
Identifying factors associated with complete resolution of heartburn (HB) during treatment may help pharmacists set appropriate expectations for patients using over-the-counter (OTC) proton-pump inhibitor therapy.
Data were pooled from the first 14 days in subjects with frequent HB or other reflux symptoms randomly assigned to double-blind.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.